Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Becton, Dickinson & Co., liquidity ratios (quarterly data)
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Becton, Dickinson & Co. current ratio deteriorated from Q4 2021 to Q1 2022 but then improved from Q1 2022 to Q2 2022 exceeding Q4 2021 level. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Becton, Dickinson & Co. quick ratio deteriorated from Q4 2021 to Q1 2022 but then improved from Q1 2022 to Q2 2022 exceeding Q4 2021 level. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Becton, Dickinson & Co. cash ratio deteriorated from Q4 2021 to Q1 2022 but then improved from Q1 2022 to Q2 2022 exceeding Q4 2021 level. |
Current Ratio
Becton, Dickinson & Co., current ratio calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Current assets | 10,152) | 8,307) | 8,838) | 9,538) | 10,000) | 9,537) | 8,969) | 8,827) | 8,555) | 6,438) | 6,664) | 6,781) | 6,844) | 6,941) | 7,411) | 7,525) | 7,512) | 7,542) | 18,633) | 18,212) | 4,891) | 5,187) | 6,367) | 6,534) | 6,612) | 5,641) | ||||||||
| Current liabilities | 6,657) | 6,735) | 6,626) | 7,749) | 5,376) | 7,021) | 5,836) | 6,067) | 8,755) | 6,726) | 5,655) | 6,237) | 7,108) | 7,145) | 7,216) | 6,106) | 4,426) | 4,895) | 3,342) | 3,273) | 4,018) | 4,570) | 4,400) | 4,219) | 4,380) | 4,529) | ||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||||||||
| Current ratio1 | 1.53 | 1.23 | 1.33 | 1.23 | 1.86 | 1.36 | 1.54 | 1.45 | 0.98 | 0.96 | 1.18 | 1.09 | 0.96 | 0.97 | 1.03 | 1.23 | 1.70 | 1.54 | 5.58 | 5.56 | 1.22 | 1.14 | 1.45 | 1.55 | 1.51 | 1.25 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Current Ratio, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 2.01 | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | 1.72 | 1.70 | 1.57 | 1.43 | 1.44 | 1.54 | 1.68 | 1.58 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 0.83 | 0.81 | 0.83 | 0.70 | 0.72 | 0.76 | 0.77 | 0.79 | 0.83 | 0.76 | 0.74 | 0.61 | 0.65 | 0.64 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 0.91 | 0.88 | 0.88 | 0.94 | 0.95 | 0.93 | 0.91 | 0.95 | 0.98 | 0.99 | 0.94 | 0.92 | 0.95 | 0.95 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 1.75 | 1.68 | 1.43 | 1.48 | 2.26 | 2.05 | 1.86 | 2.08 | 2.20 | 1.32 | 5.19 | 3.43 | 2.32 | 2.18 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 1.36 | 1.36 | 1.47 | 1.48 | 1.49 | 1.57 | 1.55 | 1.59 | 1.64 | 1.53 | 1.65 | 1.70 | 1.64 | 1.61 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.53 | 1.53 | 1.62 | 1.72 | 1.71 | 1.67 | 1.77 | 1.81 | 1.69 | 1.66 | 1.82 | 1.83 | 1.75 | 1.65 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 5.36 | 5.22 | 5.08 | 5.58 | 5.99 | 6.71 | 6.86 | 7.04 | 6.38 | 4.96 | 4.53 | 4.64 | 5.04 | 5.44 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 2.91 | 2.89 | 2.65 | 2.10 | 2.16 | 1.87 | 2.13 | 2.75 | 2.77 | 2.67 | 2.59 | 2.36 | 2.56 | 2.46 | 2.28 | 2.43 | 2.40 | 1.64 | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 0.77 | 0.78 | 0.79 | 0.77 | 0.77 | 0.74 | 0.74 | 0.82 | 0.84 | 0.75 | 0.69 | 0.70 | 0.67 | 0.73 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
1 Q2 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 10,152 ÷ 6,657 = 1.53
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Becton, Dickinson & Co. current ratio deteriorated from Q4 2021 to Q1 2022 but then improved from Q1 2022 to Q2 2022 exceeding Q4 2021 level. |
Quick Ratio
Becton, Dickinson & Co., quick ratio calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Cash and equivalents | 3,147) | 1,903) | 2,283) | 3,153) | 3,734) | 3,248) | 2,825) | 2,882) | 2,351) | 560) | 536) | 523) | 686) | 943) | 1,140) | 1,384) | 1,251) | 1,124) | 14,179) | 13,852) | 548) | 919) | 1,541) | 1,686) | 1,696) | 1,583) | ||||||||
| Restricted cash | 173) | 144) | 109) | 128) | 164) | 199) | 92) | 82) | 88) | 49) | 54) | 71) | 81) | 98) | 96) | 125) | 167) | 113) | —) | —) | —) | —) | —) | —) | —) | —) | ||||||||
| Short-term investments | 15) | 8) | 12) | 24) | 24) | 17) | 20) | 22) | 6) | 8) | 30) | 12) | 10) | 5) | 17) | 15) | 16) | 84) | 21) | 17) | 8) | 18) | 27) | 15) | 15) | 10) | ||||||||
| Trade receivables, net | 2,303) | 2,177) | 2,497) | 2,078) | 2,118) | 2,370) | 2,398) | 1,993) | 2,160) | 2,074) | 2,345) | 2,220) | 2,279) | 2,216) | 2,319) | 2,243) | 2,293) | 2,000) | 1,744) | 1,749) | 1,569) | 1,518) | 1,618) | 1,618) | 1,574) | 1,513) | ||||||||
| Total quick assets | 5,638) | 4,232) | 4,901) | 5,383) | 6,040) | 5,834) | 5,335) | 4,979) | 4,605) | 2,691) | 2,965) | 2,826) | 3,056) | 3,262) | 3,572) | 3,767) | 3,727) | 3,321) | 15,944) | 15,618) | 2,125) | 2,455) | 3,186) | 3,319) | 3,285) | 3,106) | ||||||||
| Current liabilities | 6,657) | 6,735) | 6,626) | 7,749) | 5,376) | 7,021) | 5,836) | 6,067) | 8,755) | 6,726) | 5,655) | 6,237) | 7,108) | 7,145) | 7,216) | 6,106) | 4,426) | 4,895) | 3,342) | 3,273) | 4,018) | 4,570) | 4,400) | 4,219) | 4,380) | 4,529) | ||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||||||||
| Quick ratio1 | 0.85 | 0.63 | 0.74 | 0.69 | 1.12 | 0.83 | 0.91 | 0.82 | 0.53 | 0.40 | 0.52 | 0.45 | 0.43 | 0.46 | 0.50 | 0.62 | 0.84 | 0.68 | 4.77 | 4.77 | 0.53 | 0.54 | 0.72 | 0.79 | 0.75 | 0.69 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 1.33 | 1.21 | 1.28 | 1.25 | 1.19 | 1.16 | 1.14 | 1.01 | 0.93 | 0.83 | 0.88 | 0.93 | 0.98 | 0.94 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 0.52 | 0.48 | 0.48 | 0.58 | 0.59 | 0.64 | 0.66 | 0.46 | 0.50 | 0.42 | 0.41 | 0.51 | 0.53 | 0.53 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 0.62 | 0.54 | 0.55 | 0.59 | 0.58 | 0.54 | 0.53 | 0.58 | 0.63 | 0.60 | 0.52 | 0.52 | 0.54 | 0.55 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 1.13 | 1.08 | 0.89 | 0.93 | 1.67 | 1.51 | 1.36 | 1.52 | 1.59 | 0.92 | 4.68 | 2.99 | 1.78 | 1.58 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 1.22 | 1.23 | 1.33 | 1.33 | 1.35 | 1.43 | 1.42 | 1.45 | 1.49 | 1.37 | 1.52 | 1.58 | 1.51 | 1.49 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.21 | 1.21 | 1.20 | 1.32 | 1.28 | 1.26 | 1.37 | 1.47 | 1.35 | 1.29 | 1.47 | 1.51 | 1.36 | 1.32 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 4.49 | 4.40 | 4.34 | 4.66 | 5.12 | 5.76 | 5.96 | 5.93 | 5.40 | 4.00 | 3.75 | 3.80 | 4.15 | 4.53 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 2.07 | 2.06 | 1.91 | 1.58 | 1.63 | 1.37 | 1.50 | 2.05 | 2.02 | 1.95 | 1.90 | 1.69 | 1.88 | 1.83 | 1.71 | 1.85 | 1.84 | 1.25 | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 0.71 | 0.72 | 0.72 | 0.71 | 0.71 | 0.68 | 0.68 | 0.75 | 0.76 | 0.66 | 0.63 | 0.64 | 0.62 | 0.66 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
1 Q2 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 5,638 ÷ 6,657 = 0.85
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Becton, Dickinson & Co. quick ratio deteriorated from Q4 2021 to Q1 2022 but then improved from Q1 2022 to Q2 2022 exceeding Q4 2021 level. |
Cash Ratio
Becton, Dickinson & Co., cash ratio calculation (quarterly data)
| Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||||||||||
| Cash and equivalents | 3,147) | 1,903) | 2,283) | 3,153) | 3,734) | 3,248) | 2,825) | 2,882) | 2,351) | 560) | 536) | 523) | 686) | 943) | 1,140) | 1,384) | 1,251) | 1,124) | 14,179) | 13,852) | 548) | 919) | 1,541) | 1,686) | 1,696) | 1,583) | ||||||||
| Restricted cash | 173) | 144) | 109) | 128) | 164) | 199) | 92) | 82) | 88) | 49) | 54) | 71) | 81) | 98) | 96) | 125) | 167) | 113) | —) | —) | —) | —) | —) | —) | —) | —) | ||||||||
| Short-term investments | 15) | 8) | 12) | 24) | 24) | 17) | 20) | 22) | 6) | 8) | 30) | 12) | 10) | 5) | 17) | 15) | 16) | 84) | 21) | 17) | 8) | 18) | 27) | 15) | 15) | 10) | ||||||||
| Total cash assets | 3,335) | 2,055) | 2,404) | 3,305) | 3,922) | 3,464) | 2,937) | 2,986) | 2,445) | 617) | 620) | 606) | 777) | 1,046) | 1,253) | 1,524) | 1,434) | 1,321) | 14,200) | 13,869) | 556) | 937) | 1,568) | 1,701) | 1,711) | 1,593) | ||||||||
| Current liabilities | 6,657) | 6,735) | 6,626) | 7,749) | 5,376) | 7,021) | 5,836) | 6,067) | 8,755) | 6,726) | 5,655) | 6,237) | 7,108) | 7,145) | 7,216) | 6,106) | 4,426) | 4,895) | 3,342) | 3,273) | 4,018) | 4,570) | 4,400) | 4,219) | 4,380) | 4,529) | ||||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||||||||
| Cash ratio1 | 0.50 | 0.31 | 0.36 | 0.43 | 0.73 | 0.49 | 0.50 | 0.49 | 0.28 | 0.09 | 0.11 | 0.10 | 0.11 | 0.15 | 0.17 | 0.25 | 0.32 | 0.27 | 4.25 | 4.24 | 0.14 | 0.21 | 0.36 | 0.40 | 0.39 | 0.35 | ||||||||
| Benchmarks | ||||||||||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | ||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 0.75 | 0.65 | 0.78 | 0.75 | 0.71 | 0.67 | 0.60 | 0.46 | 0.46 | 0.34 | 0.38 | 0.41 | 0.37 | 0.36 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 0.11 | 0.12 | 0.14 | 0.13 | 0.15 | 0.24 | 0.32 | 0.15 | 0.20 | 0.13 | 0.14 | 0.17 | 0.17 | 0.20 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 0.22 | 0.16 | 0.18 | 0.20 | 0.17 | 0.15 | 0.18 | 0.19 | 0.27 | 0.21 | 0.15 | 0.14 | 0.17 | 0.16 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Danaher Corp. | 0.53 | 0.49 | 0.32 | 0.35 | 1.07 | 0.93 | 0.82 | 0.94 | 0.99 | 0.52 | 4.04 | 2.40 | 1.08 | 0.84 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 0.86 | 0.86 | 0.95 | 0.97 | 0.97 | 1.08 | 1.04 | 1.04 | 1.10 | 0.95 | 1.08 | 1.14 | 1.07 | 1.04 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Humana Inc. | 1.02 | 1.02 | 1.08 | 1.20 | 1.12 | 1.12 | 1.29 | 1.39 | 1.22 | 1.16 | 1.37 | 1.44 | 1.28 | 1.15 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 3.78 | 3.58 | 3.66 | 3.98 | 4.42 | 5.04 | 5.30 | 5.27 | 4.85 | 3.44 | 3.13 | 3.11 | 3.37 | 3.79 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 1.37 | 1.36 | 1.27 | 1.17 | 1.18 | 0.99 | 1.06 | 1.33 | 1.27 | 1.25 | 1.16 | 1.03 | 1.20 | 1.21 | 1.11 | 1.32 | 1.29 | 0.86 | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 0.36 | 0.37 | 0.36 | 0.35 | 0.35 | 0.33 | 0.33 | 0.37 | 0.42 | 0.35 | 0.28 | 0.30 | 0.32 | 0.32 | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-K (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-Q (reporting date: 2015-12-31).
1 Q2 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 3,335 ÷ 6,657 = 0.50
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Becton, Dickinson & Co. cash ratio deteriorated from Q4 2021 to Q1 2022 but then improved from Q1 2022 to Q2 2022 exceeding Q4 2021 level. |